Rocket Lab Posted Record Revenue and a $2.36 Billion Backlog. Why Is the Stock Down 57% From Its Highs?

Key Stats for Rocket Lab Stock

• 52-Week Range: $37.57 to $151.00
• Street Mean Target: ~$113
• Street High Target: $150
• YTD Return: -11%
• Cash and Marketable Securities: ~$2.39B
• Fwd 2-Yr Revenue CAGR: ~50%

Value your favorite stocks like Rocket Lab with 5 years of analysts’ forecasts using TIKR’s new Valuation Model (It’s free) >>>

Rocket Lab’s Operational Story Has Never Been Stronger

Rocket Lab (RKLB) is one of the few companies in the world capable of launching satellites into orbit on its own rockets, and it has been doing so commercially since 2018.

Its Electron rocket, a small-lift vehicle designed for dedicated satellite launches, has now completed well over 50 missions and is the second most frequently launched orbital rocket in the United States after SpaceX’s Falcon 9.

Beyond launch, Rocket Lab operates a fast-growing Space Systems division that designs and manufactures satellites, spacecraft components, and subsystems for government and commercial customers. That business has become the larger of the two by revenue, and it is where most of the near-term growth is coming from.

Second quarter revenue came in at a record $234 million, up 62% year over year and ahead of consensus. Space Systems contributed $189.5 million of that, with Launch Services adding $44.6 million.

The backlog told an even more striking story, surging 137% year over year to a record $2.36 billion, and CEO Peter Beck confirmed that more than $1 billion in additional contracts had already been signed in Q3.

The revenue chart below shows how dramatically the trajectory has shifted over the past several years and where consensus expects it to go from here.

Annual revenue has grown from just $62 million in 2021 to $602 million by the end of 2025, and consensus projects nearly $953 million this year, crossing $1 billion in 2027 and approaching $2.7 billion by 2030.

Those forward estimates carry real weight given the backlog: over 90 missions on the launch manifest and billions in contracted Space Systems work give near-term revenue visibility that most growth companies at this stage simply cannot claim.

See analysts’ growth forecasts and price targets for Rocket Lab stock (It’s free) >>>

The Margin Expansion Chart Is One of the Cleanest in the Market

Revenue growth is the headline, but the gross margin trajectory is arguably the more important story for understanding whether Rocket Lab can become a sustainably profitable business. The chart below captures that trend in unusually clean terms.

Gross margin has risen every single year since 2021, climbing from negative 3% to 34.4% by the end of 2025 in an unbroken straight line.

The Q2 non-GAAP gross margin expanded further to 41.5%, up from 36.9% a year earlier, reflecting the growing mix of Space Systems revenue, which carries better unit economics than launch services alone.

Adjusted EBITDA improved to negative $8.8 million in Q2 from negative $27.6 million in the same period last year, and while the company remains unprofitable at the operating level, the direction and pace of improvement are encouraging.

The Iridium acquisition, an approximately $8 billion deal announced in Q2 that would transform Rocket Lab into a vertically integrated operator of its own satellite constellation, adds significant revenue potential but also complexity and integration risk that will take time to fully assess.

See how Rocket Lab performs against its peers in TIKR (It’s free!) >>>

What the Street Thinks and What the Neutron Question Means

At around $65, Rocket Lab has fallen roughly 57% from its 52-week high of $151, yet analyst conviction has rarely been stronger.

The Street mean target of around $113 implies upside of roughly 67% from current levels, the median sits at $120, and 14 of 19 analysts carry buy-equivalent ratings with zero underperforms or sells.

That gap between price and consensus view reflects the market’s unease with two specific overhangs, both of which the Street has apparently decided to look through.

The first is Neutron. Rocket Lab’s medium-lift reusable rocket is designed to compete for larger government and commercial payloads.

Stage 1 tank production is targeting Q4 2026 pad delivery, but Beck acknowledged on the Q2 call that the window for an actual year-end launch is narrowing, and a slip into 2027 looks increasingly likely.

The second overhang is the Iridium deal. At roughly $8 billion, it is a transformative bet that adds meaningful execution and integration risk to an already complex business. Both are legitimate concerns, and both explain why the stock trades where it does despite the operational strength underneath it.

Should You Buy Rocket Lab Stock?

Rocket Lab is executing about as well as it could at this stage of its development, with record revenue, a record backlog, steadily improving margins, and a cash position of $2.39 billion that gives it runway to see both Neutron and Iridium through to completion.

The Street’s near-unanimous bullish view and a mean target roughly 67% above the current price reflect genuine confidence in the business direction.

The risks are real: Neutron delays, Iridium integration complexity, and a stock that has already proven capable of violent swings in both directions. For investors willing to hold through that uncertainty, the operational foundation looks as solid as it ever has.

See analysts’ growth forecasts and price targets for Rocket Lab stock (It’s free!) >>>

Looking for New Opportunities?

• See which stocks billionaire investors are buying to follow the smart money.
• Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
• The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!